Plain-English translation of NCT00201526 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study that enrolls people with bipolar disorder from clinics and hospitals across Norway. Researchers will track your health over time, perform medical scans and brain activity tests, and collect blood samples for genetic research. The goal is to better understand how bipolar disorder develops and varies from person to person.
Bipolar disorder affects many people, but we still don't fully understand why some people develop it or how genetics influences the condition. This study aims to map these patterns and genetic factors so doctors can eventually develop better treatments tailored to individual patients.
You likely qualify if…
You likely don't qualify if…
You'll work with trained clinicians at your clinic or hospital who will evaluate you as part of your regular care. They'll arrange for you to have brain scans (CT, MRI, or EEG), blood tests for routine screening, and blood draws for genetic analysis. You'll be followed over several years to track how your condition progresses and to build a detailed picture of your health.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Norway
University of Oslo
Enrollment target
~3,000 participants
Started
January 2003
Primary completion
January 2030
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Arne Vaaler, PhD MD
Norwegian University of Science and Technology
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.